Close

Press Releases

TrakCel and Korber partner to provide orchestration within manufacturing of cell and gene therapies

TrakCel, a leading supplier of cellular orchestration solutions for the cell and gene therapy industry, announces it is launching a software integration resulting from a collaborative, non-exclusive partnership with Kรถrber, the specialists for complete handling systems for pharmaceutical and...

Sterling Pharma Solutions Expands Early Phase Development Capabilities at Cary

Sterling Pharma Solutions, a global contract development and manufacturing organisation, announced that it has commenced a $2.1 million expansion project to increase chemical and analytical capabilities at its facility in Cary, North Carolina. The project will include the construction of...

West Announces Landmark Collaboration with Corning in Pharmaceutical Injectable Drug Delivery

West Pharmaceutical Services, Inc., a global leader in innovative solutions for injectable drug administration, announced an exclusive supply and technology agreement with Corning Incorporated. The new collaboration includes a multimillion-dollar investment to expand Corning's Valorยฎ Glass technology to enable...

Evotec enters iPSC-based drug discovery partnership with Boehringer Ingelheim in ophthalmology

Evotec announced that the Company has entered a target and drug discovery partnership with Boehringer Ingelheim, focusing on induced pluripotent stem cell -based disease modelling for ophthalmologic disorders. Millions of people are affected by vision-related diseases worldwide, and there...

Vetter’s new clinical manufacturing site now officially authorized

Vetter, a leading global Contract Development and Manufacturing Organization (CDMO), has received the manufacturing authorization for its new site in Rankweil, Austria. As a result of the successful inspection held by the responsible national regulatory authority, the Austrian Agency...

Merck and Ridgeback Announce Supply Agreement with UNICEF for Molnupiravir, an Investigational Oral Antiviral COVID-19 Medicine

Merck, known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics announced the signing of a long-term supply agreement with the United Nations Childrenโ€™s Fund (UNICEF) to facilitate broad global access for molnupiravir, an investigational oral antiviral...

2022 will see pharma target nutraceutical products to tap into consumer spending on preventative health

CPhI Worldwide โ€“ the worldโ€™s largest pharma event, which will be hosted at the Frankfurt Messe (1-3 November, 2022) โ€“ releases the final part of its annual report with far reaching predictions for 2022 and beyond into 2025 for...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate ยป